Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 268

1.

Influenza Vaccination Rates in Adults with Psoriasis Compared to Adults with Other Chronic Diseases.

Noe MH, Shin DB, Hubbard RA, Hennessy S, Gelfand JM.

J Invest Dermatol. 2018 Oct 10. pii: S0022-202X(18)32658-7. doi: 10.1016/j.jid.2018.09.012. [Epub ahead of print] No abstract available.

2.

Association Between Aortic Vascular Inflammation and Coronary Artery Plaque Characteristics in Psoriasis.

Joshi AA, Lerman JB, Dey AK, Sajja AP, Belur AD, Elnabawi YA, Rodante JA, Aberra TM, Chung J, Salahuddin T, Natarajan B, Dave J, Goyal A, Groenendyk JW, Rivers JP, Baumer Y, Teague HL, Playford MP, Bluemke DA, Ahlman MA, Chen MY, Gelfand JM, Mehta NN.

JAMA Cardiol. 2018 Oct 1;3(10):949-956. doi: 10.1001/jamacardio.2018.2769.

PMID:
30208407
3.

Stigmatizing attitudes toward persons with psoriasis among laypersons and medical students.

Pearl RL, Wan MT, Takeshita J, Gelfand JM.

J Am Acad Dermatol. 2018 Aug 29. pii: S0190-9622(18)32465-4. doi: 10.1016/j.jaad.2018.08.014. [Epub ahead of print]

PMID:
30171876
4.

Definition and Consensus Diagnostic Criteria for Neurosarcoidosis: From the Neurosarcoidosis Consortium Consensus Group.

Stern BJ, Royal W 3rd, Gelfand JM, Clifford DB, Tavee J, Pawate S, Berger JR, Aksamit AJ, Krumholz A, Pardo CA, Moller DR, Judson MA, Drent M, Baughman RP.

JAMA Neurol. 2018 Aug 27. doi: 10.1001/jamaneurol.2018.2295. [Epub ahead of print]

PMID:
30167654
5.

Toward a low-cost, in-home, telemedicine-enabled assessment of disability in multiple sclerosis.

Bove R, Bevan C, Crabtree E, Zhao C, Gomez R, Garcha P, Morrissey J, Dierkhising J, Green AJ, Hauser SL, Cree BA, Wallin MT, Gelfand JM.

Mult Scler. 2018 Aug 24:1352458518793527. doi: 10.1177/1352458518793527. [Epub ahead of print]

PMID:
30141729
6.

Content and construct validity, predictors, and distribution of self-reported atopic dermatitis severity in US adults.

Silverberg JI, Chiesa Fuxench ZC, Gelfand JM, Margolis DJ, Boguniewicz M, Fonacier L, Grayson MH, Simpson EL, Ong PY.

Ann Allergy Asthma Immunol. 2018 Aug 6. pii: S1081-1206(18)30626-4. doi: 10.1016/j.anai.2018.07.040. [Epub ahead of print]

7.

Association of atopic dermatitis with allergic, autoimmune and cardiovascular comorbidities in US adults.

Silverberg JI, Gelfand JM, Margolis D, Boguniewicz M, Fonacier L, Grayson MH, Simpson EL, Ong P, Chiesa Fuxench ZC.

Ann Allergy Asthma Immunol. 2018 Aug 6. pii: S1081-1206(18)30628-8. doi: 10.1016/j.anai.2018.07.042. [Epub ahead of print] No abstract available.

8.

Autoimmune encephalitis after herpes simplex encephalitis: insights into pathogenesis.

Gelfand JM.

Lancet Neurol. 2018 Sep;17(9):733-735. doi: 10.1016/S1474-4422(18)30279-5. Epub 2018 Jul 23. No abstract available.

PMID:
30049613
9.

Patient burden and quality of life in atopic dermatitis in US adults: A population-based cross-sectional study.

Silverberg JI, Gelfand JM, Margolis DJ, Boguniewicz M, Fonacier L, Grayson MH, Simpson EL, Ong PY, Chiesa Fuxench ZC.

Ann Allergy Asthma Immunol. 2018 Sep;121(3):340-347. doi: 10.1016/j.anai.2018.07.006. Epub 2018 Jul 16.

10.

Severity strata for POEM, PO-SCORAD, and DLQI in US adults with atopic dermatitis.

Silverberg JI, Gelfand JM, Margolis DJ, Fonacier L, Boguniewicz M, Schwartz LB, Simpson E, Grayson MH, Ong PY, Fuxench ZCC.

Ann Allergy Asthma Immunol. 2018 Oct;121(4):464-471. doi: 10.1016/j.anai.2018.07.004. Epub 2018 Jul 9.

11.

Head-to-head trials of systemic psoriasis therapies: a systematic review of study design and maximum acceptable treatment differences.

Wan MT, Alvarez J, Shin DB, Dommasch ED, Wu JJ, Gelfand JM.

J Eur Acad Dermatol Venereol. 2018 Jul 10. doi: 10.1111/jdv.15174. [Epub ahead of print] Review.

PMID:
29989662
12.

Author response: Infliximab for the treatment of CNS sarcoidosis: A multi-institutional series.

Bradshaw MJ, Gelfand JM, Pawate S.

Neurology. 2018 Jul 3;91(1):51-52. doi: 10.1212/WNL.0000000000005725. No abstract available.

PMID:
29967208
13.

Building a Citizen Pscientist: Advancing Patient-Centered Psoriasis Research by Empowering Patients as Contributors and Analysts.

Sanchez IM, Shankle L, Wan MT, Afifi L, Wu JJ, Doris F, Bridges A, Boas M, Lafoy B, Truman S, Orbai AM, Takeshita J, Gelfand JM, Armstrong AW, Siegel MP, Liao W.

Dermatol Ther (Heidelb). 2018 Jun 6. doi: 10.1007/s13555-018-0242-5. [Epub ahead of print]

14.

Psoriasis: a novel risk factor for type 2 diabetes.

Gelfand JM, Wan MT.

Lancet Diabetes Endocrinol. 2018 May 21. pii: S2213-8587(18)30127-X. doi: 10.1016/S2213-8587(18)30127-X. [Epub ahead of print] No abstract available.

PMID:
29799414
15.

Distinct HLA associations of LGI1 and CASPR2-antibody diseases.

Binks S, Varley J, Lee W, Makuch M, Elliott K, Gelfand JM, Jacob S, Leite MI, Maddison P, Chen M, Geschwind MD, Grant E, Sen A, Waters P, McCormack M, Cavalleri GL, Barnardo M, Knight JC, Irani SR.

Brain. 2018 May 18. doi: 10.1093/brain/awy109. [Epub ahead of print]

16.

Effect of 2 Psoriasis Treatments on Vascular Inflammation and Novel Inflammatory Cardiovascular Biomarkers: A Randomized Placebo-Controlled Trial.

Mehta NN, Shin DB, Joshi AA, Dey AK, Armstrong AW, Duffin KC, Fuxench ZC, Harrington CL, Hubbard RA, Kalb RE, Menter A, Rader DJ, Reilly MP, Simpson EL, Takeshita J, Torigian DA, Werner TJ, Troxel AB, Tyring SK, Vanderbeek SB, Van Voorhees AS, Playford MP, Ahlman MA, Alavi A, Gelfand JM.

Circ Cardiovasc Imaging. 2018 Jun;11(6):e007394. doi: 10.1161/CIRCIMAGING.117.007394.

PMID:
29776990
17.

Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A Multicenter Retrospective Study of 377 Adult Patients from the United States.

Micheletti RG, Chiesa-Fuxench Z, Noe MH, Stephen S, Aleshin M, Agarwal A, Boggs J, Cardones AR, Chen JK, Cotliar J, Davis MDP, Dominguez A, Fox LP, Gordon S, Hamrick R, Ho B, Hughey LC, Jones LM, Kaffenberger BH, Kindley K, Kroshinsky D, Kwong BY, Miller DD, Mostaghimi A, Musiek A, Ortega-Loayza AG, Patel R, Posligua A, Rani M, Saluja S, Sharon VR, Shinkai K, John JS, Strickland N, Sun N, Wanat KA, Wetter DA, Worswick S, Yang C, Margolis DJ, Gelfand JM, Rosenbach M.

J Invest Dermatol. 2018 Jul 27. pii: S0022-202X(18)31964-X. doi: 10.1016/j.jid.2018.04.027. [Epub ahead of print]

PMID:
29758282
18.

Chronic Meningitis Investigated via Metagenomic Next-Generation Sequencing.

Wilson MR, O'Donovan BD, Gelfand JM, Sample HA, Chow FC, Betjemann JP, Shah MP, Richie MB, Gorman MP, Hajj-Ali RA, Calabrese LH, Zorn KC, Chow ED, Greenlee JE, Blum JH, Green G, Khan LM, Banerji D, Langelier C, Bryson-Cahn C, Harrington W, Lingappa JR, Shanbhag NM, Green AJ, Brew BJ, Soldatos A, Strnad L, Doernberg SB, Jay CA, Douglas V, Josephson SA, DeRisi JL.

JAMA Neurol. 2018 Aug 1;75(8):947-955. doi: 10.1001/jamaneurol.2018.0463.

19.

Prospective Cohort Study Investigating Changes in Body Image, Quality of Life, and Self-Esteem Following Minimally Invasive Cosmetic Procedures.

Sobanko JF, Dai J, Gelfand JM, Sarwer DB, Percec I.

Dermatol Surg. 2018 Aug;44(8):1121-1128. doi: 10.1097/DSS.0000000000001523.

PMID:
29659404
20.

Sleep disturbance and symptom burden in sarcoidosis.

Benn BS, Lehman Z, Kidd SA, Miaskowski C, Sunwoo BY, Ho M, Sun S, Ramstein J, Gelfand JM, Koth LL.

Respir Med. 2018 Mar 24. pii: S0954-6111(18)30085-4. doi: 10.1016/j.rmed.2018.03.021. [Epub ahead of print]

PMID:
29628134
21.

Commentary: Does biologic treatment of psoriasis lower the risk of cardiovascular events and mortality?: A critical question that we are only just beginning to answer.

Gelfand JM.

J Am Acad Dermatol. 2018 Jul;79(1):69-70. doi: 10.1016/j.jaad.2018.03.046. Epub 2018 Apr 3. No abstract available.

PMID:
29625133
22.

Focal cerebral β-amyloid angiopathy: A distinct clinicopathologic presentation.

Karageorgiou E, Naasan G, Pleasure SJ, Alexandrescu S, Gelfand JM, Tammewar G, Miller BL, Rabinovici GD, Grinberg LT.

Neurol Clin Pract. 2017 Oct;7(5):444-448. doi: 10.1212/CPJ.0000000000000354. No abstract available.

23.

Migraine is common in patients with sarcoidosis.

Gelfand JM, Gelfand AA, Goadsby PJ, Benn BS, Koth LL.

Cephalalgia. 2018 Jan 1:333102418768037. doi: 10.1177/0333102418768037. [Epub ahead of print]

PMID:
29580067
24.

Rituximab before and during pregnancy: A systematic review, and a case series in MS and NMOSD.

Das G, Damotte V, Gelfand JM, Bevan C, Cree BAC, Do L, Green AJ, Hauser SL, Bove R.

Neurol Neuroimmunol Neuroinflamm. 2018 Mar 19;5(3):e453. doi: 10.1212/NXI.0000000000000453. eCollection 2018 May.

25.

The state of clinical research in neurology.

Hall DA, Ramos AR, Gelfand JM, Videnovic A, Benatar M, Cahill C, Kluger BM, Goldman M.

Neurology. 2018 Apr 10;90(15):e1347-e1354. doi: 10.1212/WNL.0000000000005295. Epub 2018 Mar 16.

PMID:
29549220
26.

Reduced contrast sensitivity among older women is associated with increased risk of cognitive impairment.

Ward ME, Gelfand JM, Lui LY, Ou Y, Green AJ, Stone K, Pedula KL, Cummings SR, Yaffe K.

Ann Neurol. 2018 Apr;83(4):730-738. doi: 10.1002/ana.25196. Epub 2018 Apr 11.

PMID:
29518257
27.

Risk of Serious Infection, Opportunistic Infection, and Herpes Zoster among Patients with Psoriasis in the United Kingdom.

Takeshita J, Shin DB, Ogdie A, Gelfand JM.

J Invest Dermatol. 2018 Aug;138(8):1726-1735. doi: 10.1016/j.jid.2018.01.039. Epub 2018 Mar 2.

PMID:
29505759
28.

Research Techniques Made Simple: Pharmacoepidemiology Research Methods in Dermatology.

Noe MH, Gelfand JM.

J Invest Dermatol. 2018 Feb;138(2):e13-e18. doi: 10.1016/j.jid.2017.10.026.

PMID:
29389330
29.

Chronic skin inflammation accelerates macrophage cholesterol crystal formation and atherosclerosis.

Baumer Y, Ng Q, Sanda GE, Dey AK, Teague HL, Sorokin AV, Dagur PK, Silverman JI, Harrington CL, Rodante JA, Rose SM, Varghese NJ, Belur AD, Goyal A, Gelfand JM, Springer DA, Bleck CK, Thomas CL, Yu ZX, Winge MC, Kruth HS, Marinkovich MP, Joshi AA, Playford MP, Mehta NN.

JCI Insight. 2018 Jan 11;3(1). pii: 97179. doi: 10.1172/jci.insight.97179. [Epub ahead of print]

30.

Harnessing electronic medical records to advance research on multiple sclerosis.

Damotte V, Lizée A, Tremblay M, Agrawal A, Khankhanian P, Santaniello A, Gomez R, Lincoln R, Tang W, Chen T, Lee N, Villoslada P, Hollenbach JA, Bevan CD, Graves J, Bove R, Goodin DS, Green AJ, Baranzini SE, Cree BA, Henry RG, Hauser SL, Gelfand JM, Gourraud PA.

Mult Scler. 2018 Jan 1:1352458517747407. doi: 10.1177/1352458517747407. [Epub ahead of print]

PMID:
29310490
31.

Pleocytosis is not fully responsible for low CSF glucose in meningitis.

Baud MO, Vitt JR, Robbins NM, Wabl R, Wilson MR, Chow FC, Gelfand JM, Josephson SA, Miller S.

Neurol Neuroimmunol Neuroinflamm. 2017 Dec 22;5(1):e425. doi: 10.1212/NXI.0000000000000425. eCollection 2018 Jan.

32.

The importance of early immunotherapy in patients with faciobrachial dystonic seizures.

Thompson J, Bi M, Murchison AG, Makuch M, Bien CG, Chu K, Farooque P, Gelfand JM, Geschwind MD, Hirsch LJ, Somerville E, Lang B, Vincent A, Leite MI, Waters P, Irani SR; Faciobrachial Dystonic Seizures Study Group .

Brain. 2018 Feb 1;141(2):348-356. doi: 10.1093/brain/awx323.

33.

Health care utilization for psoriasis in the United States differs by race: An analysis of the 2001-2013 Medical Expenditure Panel Surveys.

Fischer AH, Shin DB, Gelfand JM, Takeshita J.

J Am Acad Dermatol. 2018 Jan;78(1):200-203. doi: 10.1016/j.jaad.2017.07.052. No abstract available.

PMID:
29241786
34.

Psoriasis and the risk of diabetes: A prospective population-based cohort study.

Wan MT, Shin DB, Hubbard RA, Noe MH, Mehta NN, Gelfand JM.

J Am Acad Dermatol. 2018 Feb;78(2):315-322.e1. doi: 10.1016/j.jaad.2017.10.050. Epub 2017 Nov 8.

PMID:
29128465
35.

Risk of Incident Liver Disease in Patients with Psoriasis, Psoriatic Arthritis, and Rheumatoid Arthritis: A Population-Based Study.

Ogdie A, Grewal SK, Noe MH, Shin DB, Takeshita J, Chiesa Fuxench ZC, Carr RM, Gelfand JM.

J Invest Dermatol. 2018 Apr;138(4):760-767. doi: 10.1016/j.jid.2017.10.024. Epub 2017 Nov 2.

PMID:
29104161
36.

Smoking paradox in the development of psoriatic arthritis among patients with psoriasis: a population-based study.

Nguyen UDT, Zhang Y, Lu N, Louie-Gao Q, Niu J, Ogdie A, Gelfand JM, LaValley MP, Dubreuil M, Sparks JA, Karlson EW, Choi HK.

Ann Rheum Dis. 2018 Jan;77(1):119-123. doi: 10.1136/annrheumdis-2017-211625. Epub 2017 Nov 4.

PMID:
29102956
37.

Visceral Adiposity in Psoriasis is Associated With Vascular Inflammation by 18F-Fluorodeoxyglucose Positron-Emission Tomography/Computed Tomography Beyond Cardiometabolic Disease Risk Factors in an Observational Cohort Study.

Rivers JP, Powell-Wiley TM, Dey AK, Rodante JA, Chung JH, Joshi AA, Natarajan B, Sajja AP, Chaturvedi A, Rana A, Harrington CL, Teague HL, Lockshin BN, Ahlman MA, Yao J, Playford MP, Gelfand JM, Mehta NN.

JACC Cardiovasc Imaging. 2018 Feb;11(2 Pt 2):349-357. doi: 10.1016/j.jcmg.2017.08.014. Epub 2017 Oct 18.

PMID:
29055628
38.

Demystifying Neurosarcoidosis and Informing Prognosis.

Gelfand JM.

JAMA Neurol. 2017 Nov 1;74(11):1296-1298. doi: 10.1001/jamaneurol.2017.1473. No abstract available.

PMID:
29052731
39.

Infliximab for the treatment of CNS sarcoidosis: A multi-institutional series.

Gelfand JM, Bradshaw MJ, Stern BJ, Clifford DB, Wang Y, Cho TA, Koth LL, Hauser SL, Dierkhising J, Vu N, Sriram S, Moses H, Bagnato F, Kaufmann JA, Ammah DJ, Yohannes TH, Hamblin MJ, Venna N, Green AJ, Pawate S.

Neurology. 2017 Nov 14;89(20):2092-2100. doi: 10.1212/WNL.0000000000004644. Epub 2017 Oct 13.

PMID:
29030454
40.

Clemastine fumarate as a remyelinating therapy for multiple sclerosis (ReBUILD): a randomised, controlled, double-blind, crossover trial.

Green AJ, Gelfand JM, Cree BA, Bevan C, Boscardin WJ, Mei F, Inman J, Arnow S, Devereux M, Abounasr A, Nobuta H, Zhu A, Friessen M, Gerona R, von Büdingen HC, Henry RG, Hauser SL, Chan JR.

Lancet. 2017 Dec 2;390(10111):2481-2489. doi: 10.1016/S0140-6736(17)32346-2. Epub 2017 Oct 10.

41.

The burden of atopic dermatitis in US adults: Health care resource utilization data from the 2013 National Health and Wellness Survey.

Eckert L, Gupta S, Amand C, Gadkari A, Mahajan P, Gelfand JM.

J Am Acad Dermatol. 2018 Jan;78(1):54-61.e1. doi: 10.1016/j.jaad.2017.08.002. Epub 2017 Oct 7.

42.

Clinical and imaging correlation in patients with pathologically confirmed tumefactive demyelinating lesions.

Tremblay MA, Villanueva-Meyer JE, Cha S, Tihan T, Gelfand JM.

J Neurol Sci. 2017 Oct 15;381:83-87. doi: 10.1016/j.jns.2017.08.015. Epub 2017 Aug 10.

43.

Reply to: "Statistical and methodological issues".

Shin TM, Shaikh WR, Etzkorn JR, Sobanko JF, Margolis DJ, Gelfand JM, Chu EY, Elenitsas R, Miller CJ.

J Am Acad Dermatol. 2017 Oct;77(4):e115-e116. doi: 10.1016/j.jaad.2017.05.030. No abstract available.

PMID:
28917479
44.

Unraveling Vascular Inflammation: From Immunology to Imaging.

Teague HL, Ahlman MA, Alavi A, Wagner DD, Lichtman AH, Nahrendorf M, Swirski FK, Nestle F, Gelfand JM, Kaplan MJ, Grinspoon S, Ridker PM, Newby DE, Tawakol A, Fayad ZA, Mehta NN.

J Am Coll Cardiol. 2017 Sep 12;70(11):1403-1412. doi: 10.1016/j.jacc.2017.07.750. Review.

45.

Objective Measures of Psoriasis Severity Predict Mortality: A Prospective Population-Based Cohort Study.

Noe MH, Shin DB, Wan MT, Gelfand JM.

J Invest Dermatol. 2018 Jan;138(1):228-230. doi: 10.1016/j.jid.2017.07.841. Epub 2017 Aug 23. No abstract available. Erratum in: J Invest Dermatol. 2018 Apr;138(4):998.

PMID:
28843488
46.

The relationship between duration of psoriasis, vascular inflammation, and cardiovascular events.

Egeberg A, Skov L, Joshi AA, Mallbris L, Gislason GH, Wu JJ, Rodante J, Lerman JB, Ahlman MA, Gelfand JM, Mehta NN.

J Am Acad Dermatol. 2017 Oct;77(4):650-656.e3. doi: 10.1016/j.jaad.2017.06.028. Epub 2017 Aug 18.

47.

National Psoriasis Foundation Priorities for Patient-Centered Research: Proceedings from the 2016 Conference.

Afifi L, Shankle L, Armstrong AW, Boas M, Bridges A, Chiguil V, Doris F, Callis Duffin K, Fielding E, Fleischmann R, Gelfand JM, Kiselica M, Kiselica C, LaFoy B, Latella JJ, Takeshita J, Truman S, Wan MT, Wilkerson V, Wu JJ, Siegel MP, Liao W.

J Psoriasis Psoriatic Arthritis. 2017 Summer;2(3):73-80.

48.

Variations in risk of asthma and seasonal allergies between early- and late-onset pediatric atopic dermatitis: A cohort study.

Wan J, Mitra N, Hoffstad OJ, Gelfand JM, Yan AC, Margolis DJ.

J Am Acad Dermatol. 2017 Oct;77(4):634-640. doi: 10.1016/j.jaad.2017.06.013. Epub 2017 Aug 14.

49.

How similar are the treatment responses to biosimilars in patients with psoriasis? A systematic review of statistical margins in comparative clinical trials.

Wan MT, Strober BE, Wu JJ, Shin DB, Gelfand JM.

J Am Acad Dermatol. 2017 Sep;77(3):569-572. doi: 10.1016/j.jaad.2017.05.032. Review. No abstract available.

50.

Clinical and Biological Insights from the University of California San Francisco Prospective and Longitudinal Cohort.

Benn BS, Lehman Z, Kidd SA, Ho M, Sun S, Ramstein J, Arger NK, Nguyen CP, Su R, Gomez A, Gelfand JM, Koth LL.

Lung. 2017 Oct;195(5):553-561. doi: 10.1007/s00408-017-0037-y. Epub 2017 Jul 13.

PMID:
28707108

Supplemental Content

Loading ...
Support Center